The LAT1 inhibitor JPH203 inhibits not only the proliferative pathway and amino acid metabolism, but also the tumor stromal reaction, and it may therefore serve as an effective novel therapeutic agent. The gene discussed is SLC7A5; the disease is neoplasm.